H1N1 Vaccines Market Research Report by Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines), by Vaccine Type (Intraderma, Intramuscular, and Intranasal), by Type of Brand, by Distribution Channel, by State (Cali

H1N1 Vaccines Market Research Report by Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines), by Vaccine Type (Intraderma, Intramuscular, and Intranasal), by Type of Brand, by Distribution Channel, by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19

The United States H1N1 Vaccines Market size was estimated at USD 775.99 million in 2020 and expected to reach USD 1,104.25 million in 2021, at a CAGR 38.76% to reach USD 5,540.57 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the H1N1 Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Route of Administration, the market was studied across Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines.

Based on Vaccine Type, the market was studied across Intraderma, Intramuscular, and Intranasal.

Based on Type of Brand, the market was studied across Agripal, Fiuarix, Influgen, Influvac, Nasovac, Others, and Vaxigrip.

Based on Distribution Channel, the market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the H1N1 Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States H1N1 Vaccines Market, including Abbott, Baxter International, Cipla, GSK, Hualan Biological Engineering, Merck, Mitsubishi Tanabe Pharma, Pfizer, Sanofi, and Sinovac Biotech.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States H1N1 Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States H1N1 Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States H1N1 Vaccines Market?
4. What is the competitive strategic window for opportunities in the United States H1N1 Vaccines Market?
5. What are the technology trends and regulatory frameworks in the United States H1N1 Vaccines Market?
6. What is the market share of the leading vendors in the United States H1N1 Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the United States H1N1 Vaccines Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. H1N1 Vaccines Market, by Route of Administration
6.1. Introduction
6.2. Intradermal Vaccines
6.3. Intramuscular Vaccines
6.4. Intranasal Vaccines
7. H1N1 Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Intraderma
7.3. Intramuscular
7.4. Intranasal
8. H1N1 Vaccines Market, by Type of Brand
8.1. Introduction
8.2. Agripal
8.3. Fiuarix
8.4. Influgen
8.5. Influvac
8.6. Nasovac
8.7. Others
8.8. Vaxigrip
9. H1N1 Vaccines Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. California H1N1 Vaccines Market
11. Florida H1N1 Vaccines Market
12. Illinois H1N1 Vaccines Market
13. New York H1N1 Vaccines Market
14. Ohio H1N1 Vaccines Market
15. Pennsylvania H1N1 Vaccines Market
16. Texas H1N1 Vaccines Market
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. Abbott
18.2. Baxter International
18.3. Cipla
18.4. GSK
18.5. Hualan Biological Engineering
18.6. Merck
18.7. Mitsubishi Tanabe Pharma
18.8. Pfizer
18.9. Sanofi
18.10. Sinovac Biotech
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES H1N1 VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES H1N1 VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES H1N1 VACCINES MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
FIGURE 7. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES H1N1 VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2026 (%)
FIGURE 14. UNITED STATES H1N1 VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES H1N1 VACCINES MARKET SIZE, BY VACCINE TYPE, 2026
FIGURE 16. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRADERMA, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRADERMA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRANASAL, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRANASAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2020 VS 2026 (%)
FIGURE 23. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2026
FIGURE 25. UNITED STATES H1N1 VACCINES MARKET SIZE, BY AGRIPAL, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES H1N1 VACCINES MARKET SIZE, BY AGRIPAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES H1N1 VACCINES MARKET SIZE, BY FIUARIX, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES H1N1 VACCINES MARKET SIZE, BY FIUARIX, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INFLUGEN, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INFLUGEN, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INFLUVAC, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INFLUVAC, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES H1N1 VACCINES MARKET SIZE, BY NASOVAC, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES H1N1 VACCINES MARKET SIZE, BY NASOVAC, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES H1N1 VACCINES MARKET SIZE, BY OTHERS, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES H1N1 VACCINES MARKET SIZE, BY OTHERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES H1N1 VACCINES MARKET SIZE, BY VAXIGRIP, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES H1N1 VACCINES MARKET SIZE, BY VAXIGRIP, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 40. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 42. UNITED STATES H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 44. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACY, 2018-2026 (USD MILLION)
FIGURE 45. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 46. UNITED STATES H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACY, 2018-2026 (USD MILLION)
FIGURE 47. UNITED STATES H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 48. UNITED STATES H1N1 VACCINES MARKET: FPNV POSITIONING MATRIX
FIGURE 49. UNITED STATES H1N1 VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 50. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES H1N1 VACCINES MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES H1N1 VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES H1N1 VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES H1N1 VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRADERMA, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INTRANASAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES H1N1 VACCINES MARKET SIZE, BY AGRIPAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES H1N1 VACCINES MARKET SIZE, BY FIUARIX, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INFLUGEN, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INFLUVAC, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES H1N1 VACCINES MARKET SIZE, BY NASOVAC, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES H1N1 VACCINES MARKET SIZE, BY OTHERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES H1N1 VACCINES MARKET SIZE, BY VAXIGRIP, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES H1N1 VACCINES MARKET: SCORES
TABLE 25. UNITED STATES H1N1 VACCINES MARKET: BUSINESS STRATEGY
TABLE 26. UNITED STATES H1N1 VACCINES MARKET: PRODUCT SATISFACTION
TABLE 27. UNITED STATES H1N1 VACCINES MARKET: RANKING
TABLE 28. UNITED STATES H1N1 VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 29. UNITED STATES H1N1 VACCINES MARKET: MERGER & ACQUISITION
TABLE 30. UNITED STATES H1N1 VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 31. UNITED STATES H1N1 VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 32. UNITED STATES H1N1 VACCINES MARKET: INVESTMENT & FUNDING
TABLE 33. UNITED STATES H1N1 VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 34. UNITED STATES H1N1 VACCINES MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook